The Joslin Diabetes Center at Upstate Medical University is marking a major milestone— its 30th anniversary — celebrating three decades of advancing diabetes care, research, and education across Central New York.
Established in 1995, the Center was founded through the leadership of physician Ruth Weinstock, whose determination and collaboration with The Upstate Foundation helped secure the initial funding to bring the project to life. Key partners in this effort included then-Upstate President Gregory Eastwood, MD, campaign chairs and donors David and Jean Tye, and many other generous supporters.
Over the past three decades, Joslin at Upstate has grown into a nationally recognized leader in diabetes research and clinical care. It remains the only comprehensive diabetes center in Central New York, serving patients from more than 40 counties. The center’s dedicated team — comprising 43 adult and pediatric specialists, including physicians, advanced practice providers, and diabetes care and education experts — continues to improve the lives of thousands living with diabetes.
Under Weinstock’s leadership, the center has made significant contributions to diabetes science, with faculty and staff authoring or co-authoring more than 580 research publications since its inception. Today, Joslin at Upstate continues to pioneer advancements in diabetes treatment through ongoing clinical research and innovative new initiatives.
Joslin was one of only four such centers in the U.S. to participate in a clinical trial that found automated insulin delivery systems, especially hybrid closed-loop technologies, can reduce the risk of hypoglycemia and hyperglycemia in older adults with Type 1 diabetes. The federally funded study was published jn the New England Journal of Medicine in December 2024.